NCT03764137 2025-01-31
Panitumumab
University of Alabama at Birmingham
Phase 1/2 Withdrawn
Clinical Trials
8 trialsNCT05433402 2022-10-27
Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer
Sadat City University
Phase 1/2 Withdrawn
NCT05104905 2022-05-11
RENACOL
Faron Pharmaceuticals Ltd
Phase 1/2 Withdrawn
NCT01176500 2017-07-02
A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1/2 Withdrawn
NCT01522677 2016-12-01
A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
University of California, Irvine
Phase 1/2 Withdrawn
NCT02575508 2016-05-20
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer
Roswell Park Cancer Institute
Phase 1/2 Withdrawn
NCT00035919 2014-05-22
Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver
University of Southern California
Phase 1/2 Withdrawn
NCT01320267 2014-03-17
SILS
University of British Columbia
Phase 1/2 Withdrawn